SCHEMBL242268

SCHEMBL242268

NC(=O)N1CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL28195185 0.97 CA2 (0.52)
SCHEMBL28709291 0.97 CA2 (0.52)
Hydrochloric Acid SCHEMBL27640046 0.97 CA2 (0.52)
Water SCHEMBL15152290 0.97 CA2 (0.52)
Hydrochloric Acid SCHEMBL956960 0.97 CA2 (0.52)
SCHEMBL28848380 0.97 CA2 (0.52)
SCHEMBL28706408 0.97 CA2 (0.52)
SCHEMBL21065355 0.97 CA2 (0.52)
Bromide SCHEMBL21957301 0.97 CA2 (0.52)
SCHEMBL8029418 0.97 CA2 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3942 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4100410-B1 MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE NEUROCRINE BIOSCIENCES INC (US) 2026-04-22 EP claimed
EP-4301736-B1 MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS LEAD DISCOVERY CENTER GMBH (DE) 2025-10-08 EP claimed
EP-4619106-A2 TREATMENT OF ASCT2-DEPENDENT CANCERS Neupharma, Inc (US) 2025-09-24 EP claimed
US-12344600-B2 c-Myc mRNA translation modulators and uses thereof in the treatment of cancer ANIMA BIOTECH INC. (US) 2025-07-01 US claimed
CN-118005609-B 2-Aminopyrimidine compound and application thereof 沈阳药科大学 2025-06-17 CN claimed
EP-4554569-A1 AGENT CONTAINING MALONIC ACID OR ITS DERIVATIVES FOR RESTORING METAL HOMEOSTASIS Oxford Antibiotic Group GmbH (AT) 2025-05-21 EP claimed
CN-117800942-B Thiophene piperazine amide derivative, composition and application thereof 徐州医科大学 2025-04-25 CN claimed
CN-119866217-A Agent for restoring metal steady state containing malonic acid or derivative thereof 牛津抗生素(制药)集团股份有限公司 2025-04-22 CN claimed
CN-119816492-A TRPV2 channel blocker and use thereof 伊契洛夫科技有限公司 2025-04-11 CN claimed
US-20250109128-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2025-04-03 US claimed
WO-1985000811-A1 NOVEL 1-PIPERAZINECARBOXAMIDE DERIVATIVES AB FERROSAN (SE) 1985-02-28 WO claimed
EP-0099686-A2 Process for preparing polypiperazinamide anisotropic membranes Montedison S.p.A. (IT) 1984-02-01 EP claimed
US-4416817-A BACTERICIDES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1983-11-22 US claimed
US-4269838-A ADRENERGIC BLOCKING AGENTS; ANTIARRHYTHMIA AND HYPOTENSIVE AGENTS NIPPON SHINYAKU CO. LTD. (JP) 1981-05-26 US claimed
US-4161586-A 5-Hydroxy-PGI1 piperazinylamides THE UPJOHN COMPANY (US) 1979-07-17 US claimed
US-4137403-A 9-Deoxy-9-methylene-PGF2 cycloamides THE UPJOHN COMPANY (US) 1979-01-30 US claimed
US-4124704-A ANTIMICROBIAL RIKER LABORATORIES, INC. (US) 1978-11-07 US claimed
US-4123424-A Polymeric piperazinamides and membranes for reverse osmosis made therefrom MONTEDISON S.P.A. (IT) 1978-10-31 US claimed
US-4067993-A Antimicrobial 2-nitro-3-phenylbenzofurancarboxylic acids RIKER LABORATORIES, INC. (US) 1978-01-10 US claimed
US-3939268-A 2,4-Diamino substituted pyridol(3,2-d)pyrimidine as antithrombotic agents BOEHRINGER INGELHEIM GMBH (DT) 1976-02-17 US claimed